Thomas A. King
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Thomas A. King has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- David Robert Spring
Yusuf Hamied Department of Chemistry University of Cambridge Cambridge UK
7 shared publications - Stephen J. Walsh
Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK
3 shared publications - Thomas Wharton
Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK
3 shared publications - Hannah F. Sore
Department of Chemistry, University of Cambridge, Cambridge, UK
2 shared publications - Hannah L. Stewart
Cancer Research Horizons Newcastle Drug Discovery Unit, Chemistry, School of Natural and Environmental Sciences, Bedson Building, Newcastle University, Newcastle upon Tyne, UK
2 shared publications - Kim Thollund Mortensen
Department of Chemistry , Technical University of Denmark , DK-2800 Kongens Lyngby , Denmark
2 shared publications
Latest Publications
- Open Access
- 3 December 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (5) , 2722-2731
MMP-cleavable linker platform for tumour-responsive homo- and heterobivalent antibody–drug conjugates
Herein we report the development of a novel linker platform for tumour-responsive antibody–drug conjugates.
- 3 December 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (5) , 2722-2731
Open AccessMMP-cleavable linker platform for tumour-responsive homo- and heterobivalent antibody–drug conjugates
Herein we report the development of a novel linker platform for tumour-responsive antibody–drug conjugates.
- Open Access
- 6 May 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (23) , 10602-10609
A platform for SpyCatcher conjugation to native antibodies
We introduce a platform for the conjugation of SpyCatcher proteins to native antibodies using cysteine-reactive tetra-divinylpyrimidine (TetraDVP)-SpyTag linkers.
- 6 May 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (23) , 10602-10609
Open AccessA platform for SpyCatcher conjugation to native antibodies
We introduce a platform for the conjugation of SpyCatcher proteins to native antibodies using cysteine-reactive tetra-divinylpyrimidine (TetraDVP)-SpyTag linkers.
- Open Access
- 14 June 2024
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (8) , 976-985
Horner–Wadsworth–Emmons olefination of proteins and glycoproteins
Chemo-selective modifications of proteins are fundamental to the advancement of biological and pharmaceutical sciences. The search for biocompatible chemical reactions has prompted us to investigate Horner–Wadsworth–Emmons (HWE) olefinations, iconic reactions in organic synthesis that would give rise to new selective protein olefinations. Our choice of HWE olefinations was inspired by the growing number of methods for generating aldehydes as transient reactive groups in proteins and the potential for mild and simple reaction conditions. Here we show that HWE olefination reactions on aldehydes, produced by both chemical and enzymatic methods, are compatible with physiological conditions and highly selective in small and large proteins, including therapeutic antibodies and stable recombinant proteins exemplified by green fluorescent protein. Reaction kinetics can be fine-tuned over orders of magnitude both by judicious use of substituents and pH regulation. The electrophilic nature of the HWE olefination products can be tuned to allow for subsequent nucleophilic additions, including thiol- and phospha-Michael additions. Our results demonstrate that HWE olefination of aldehydes in proteins provides efficient and selective bioconjugation chemistries that are orthogonal to existing methods.
- 14 June 2024
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (8) , 976-985
Open AccessHorner–Wadsworth–Emmons olefination of proteins and glycoproteins
Chemo-selective modifications of proteins are fundamental to the advancement of biological and pharmaceutical sciences. The search for biocompatible chemical reactions has prompted us to investigate Horner–Wadsworth–Emmons (HWE) olefinations, iconic reactions in organic synthesis that would give rise to new selective protein olefinations. Our choice of HWE olefinations was inspired by the growing number of methods for generating aldehydes as transient reactive groups in proteins and the potential for mild and simple reaction conditions. Here we show that HWE olefination reactions on aldehydes, produced by both chemical and enzymatic methods, are compatible with physiological conditions and highly selective in small and large proteins, including therapeutic antibodies and stable recombinant proteins exemplified by green fluorescent protein. Reaction kinetics can be fine-tuned over orders of magnitude both by judicious use of substituents and pH regulation. The electrophilic nature of the HWE olefination products can be tuned to allow for subsequent nucleophilic additions, including thiol- and phospha-Michael additions. Our results demonstrate that HWE olefination of aldehydes in proteins provides efficient and selective bioconjugation chemistries that are orthogonal to existing methods.
- Open Access
- 18 July 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (65) , 9868-9871
Disulfide re-bridging reagents for single-payload antibody-drug conjugates
A tetra-reactive disulfide re-bridging reagent, TetraDVP, enables the efficient synthesis of antibody-drug conjugates (ADCs) bearing a single payload.
- 18 July 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (65) , 9868-9871
Open AccessDisulfide re-bridging reagents for single-payload antibody-drug conjugates
A tetra-reactive disulfide re-bridging reagent, TetraDVP, enables the efficient synthesis of antibody-drug conjugates (ADCs) bearing a single payload.
- Open Access
- 16 May 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (22) , 4591-4595
Synthesis of sp 3 -rich heterocyclic frameworks by a divergent synthesis strategy
Herein, we present sp 3 -rich fragments, that display optimal physicochemical properties and exit vectors ideal for fragment-based lead discovery.
- 16 May 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (22) , 4591-4595
Open AccessSynthesis of sp 3 -rich heterocyclic frameworks by a divergent synthesis strategy
Herein, we present sp 3 -rich fragments, that display optimal physicochemical properties and exit vectors ideal for fragment-based lead discovery.
- Open Access
- 11 November 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 50 (1) , 39-57
Photocatalytic methods for amino acid modification
This tutorial review introduces photocatalysis for amino acid modification and summarises recent advances in the field.
- 11 November 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 50 (1) , 39-57
Open AccessPhotocatalytic methods for amino acid modification
This tutorial review introduces photocatalysis for amino acid modification and summarises recent advances in the field.
- Open Access
- 11 May 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (50) , 6818-6821
An efficient, stereocontrolled and versatile synthetic route to bicyclic partially saturated privileged scaffolds
A simple, high yielding and scalable synthesis for diastereoselective access to privileged fused bicyclic heteroaromatic scaffolds.
- 11 May 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (50) , 6818-6821
Open AccessAn efficient, stereocontrolled and versatile synthetic route to bicyclic partially saturated privileged scaffolds
A simple, high yielding and scalable synthesis for diastereoselective access to privileged fused bicyclic heteroaromatic scaffolds.
- Open Access
- 8 July 2019
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019 (31-32) , 5219-5229
Cycloaddition Strategies for the Synthesis of Diverse Heterocyclic Spirocycles for Fragment‐Based Drug Discovery
In recent years the pharmaceutical industry has benefited from the advances made in fragment‐based drug discovery (FBDD) with more than 30 fragment‐derived drugs currently marketed or progressing through clinical trials. The success of fragment‐based drug discovery is entirely dependent upon the composition of the fragment screening libraries used. Heterocycles are prevalent within marketed drugs due to the role they play in providing binding interactions; consequently, heterocyclic fragments are important components of FBDD libraries. Current screening libraries are dominated by flat, sp2‐rich compounds, primarily owing to their synthetic tractability, despite the superior physicochemical properties displayed by more three‐dimensional scaffolds. Herein, we report step‐efficient routes to a number of biologically relevant, fragment‐like heterocyclic spirocycles. The use of both electron‐deficient and electron‐rich 2‐atom donors was explored in complexity‐generating [3+2]‐cycloadditions to furnish products in 3 steps from commercially available starting materials. The resulting compounds were primed for further fragment elaboration through the inclusion of synthetic handles from the outset of the syntheses.
- 8 July 2019
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019 (31-32) , 5219-5229
Open AccessCycloaddition Strategies for the Synthesis of Diverse Heterocyclic Spirocycles for Fragment‐Based Drug Discovery
In recent years the pharmaceutical industry has benefited from the advances made in fragment‐based drug discovery (FBDD) with more than 30 fragment‐derived drugs currently marketed or progressing through clinical trials. The success of fragment‐based drug discovery is entirely dependent upon the composition of the fragment screening libraries used. Heterocycles are prevalent within marketed drugs due to the role they play in providing binding interactions; consequently, heterocyclic fragments are important components of FBDD libraries. Current screening libraries are dominated by flat, sp2‐rich compounds, primarily owing to their synthetic tractability, despite the superior physicochemical properties displayed by more three‐dimensional scaffolds. Herein, we report step‐efficient routes to a number of biologically relevant, fragment‐like heterocyclic spirocycles. The use of both electron‐deficient and electron‐rich 2‐atom donors was explored in complexity‐generating [3+2]‐cycloadditions to furnish products in 3 steps from commercially available starting materials. The resulting compounds were primed for further fragment elaboration through the inclusion of synthetic handles from the outset of the syntheses.